NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Tricida, Inc. ( TCDA) between September 4, 2019 and October 28, 2020, inclusive (the “Class Period”).
To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=tricida-inc&id=2556 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email [email protected] for information on the class action.
如果您想加入这个集体诉讼案，请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=tricida-inc&id=2556
If you wish to serve as lead plaintiff, you must move the Court before the March 8, 2021 DEADLINE. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that- Tricida’s NDA for veverimer was materially deficient; accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and as a result, the Company’s public statements were materially false and misleading at all relevant times.
Lead plaintiff status is not required to seek compensation. You may retain counsel of your choice. You may remain an absent class member and take no action at this time.
Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.
Zhang Investor Law P.C.
99 Wall Street, Suite 232
New York, New York 10005
[email protected]
tel: (800) 991-3756
